Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Llaverias G, Pou J, Ros E, Zambón D, Cofán M, Sánchez A, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment.

    Pharmacogenomics . 9(8): 1035-1054. Nº de citas: 13

    [doi:10.2217/14622416.9.8.1035]

  • Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer FX, Laguna JC, Michalik L, Wahli W and Vazquez M.

    Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

    Diabetes . 57(8): 2149-2157. Nº de citas: 103

    [doi:10.2337/db08-0176]

  • Coll T, Eyre E, Rodríguez-Calvo R, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells.

    JOURNAL OF BIOLOGICAL CHEMISTRY . 283(17): 11107-11116. Nº de citas: 285

    [doi:10.1074/jbc.M708700200]

  • Planavila A, Rodríguez-Calvo R, Palomer FX, Coll T, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1781(1-2): 26-35. Nº de citas: 15

    [doi:10.1016/j.bbalip.2007.10.009]

  • Rodríguez-Calvo R, Serrano L, Barroso E, Coll T, Palomer FX, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(12): 1326-1336. Nº de citas: 22

    [doi:10.1093/gerona/62.12.1326]

  • Vilà L, Roglans N, Alegret M, Camins A, Pallàs M, Sánchez RM, Vazquez M and Laguna JC.

    Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(11): 1219-1227. Nº de citas: 13

    [doi:10.1093/gerona/62.11.1219]

  • Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.

    HEPATOLOGY . 45(3): 778-788. Nº de citas: 185

    [doi:10.1002/hep.21499]

  • Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.

    Diabetes . 55(10): 2779-2787. Nº de citas: 127

    [doi:10.2337/db05-1494]

  • Rodríguez-Calvo R, Jové M, Coll T, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 61(8): 773-780. Nº de citas: 27

    [doi:10.1093/gerona/61.8.773]

  • Planavila A, Rodríguez-Calvo R, de Arriba AF, Sánchez RM, Laguna JC, Merlos M and Vazquez M.

    Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.

    MOLECULAR PHARMACOLOGY . 69(4): 1174-1181. Nº de citas: 7

    [doi:10.1124/mol.105.016345]